Back to Agenda
Characterizing Drug Shortages and Their Causes: Anticipating Future Trends
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development
Center For the Study of Drug Development, United States
The incidence and scale of drug shortages have both increased markedly during the past several years. As a result, regulatory agencies, drug manufacturers, and policy makers have been focusing more attention on understanding drug shortages and mitigating associated risk. This session includes information on a 2012 study capturing robust descriptive and detailed data on the incidence of, and longitudinal trends in, drug shortages and where and why they occur. This session will also discuss the anticipated increase in the incidence of drug shortages under the rising proportion of biosimilars in the market and the impact of other forecasted drug development and commercialization trends.
Learning Objective : Describe the incidence and characteristics of drug shortages; Articulate why drug shortages occur; Anticipate factors that may increase the incidence of drug shortages in the future.
Speaker(s)
Pharmacovigilance in the Age of Biosimilars: Effectively Tracking Biologic Drug Outcomes Today and Tomorrow
Richard Dolinar, MD
Bilao, LLC, United States
Chairman
Drug Shortages: An Industry Perspective
David Gaugh, RPh
Generic Pharmaceutical Association (GPhA), United States
Senior Vice President for Sciences and Regulatory Affairs
Have an account?